Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Tamar Tadmor, Manfred Welslau & Iwona Hus. (2018) A review of the infection pathogenesis and prophylaxis recommendations in patients with chronic lymphocytic leukemia. Expert Review of Hematology 11:1, pages 57-70.
Read now
Read now
Thomas E. Lew, Chan Y. Cheah, Dennis A. Carney, H. Miles Prince, Max Wolf, Ali Bazargan, E. Henry Januszewicz, Robin Filshie, David Westerman, John F. Seymour & Constantine S. Tam. (2016) Dose-reduced fludarabine, cyclophosphamide and rituximab is well tolerated in older patients with chronic lymphocytic leukemia and has preserved therapeutic efficacy. Leukemia & Lymphoma 57:5, pages 1044-1053.
Read now
Read now
Chaitra Ujjani & Bruce D Cheson. (2012) Chronic lymphocytic leukemia: where are we and where are we going?. Expert Opinion on Pharmacotherapy 13:12, pages 1675-1677.
Read now
Read now
Articles from other publishers (8)
Katharina Müller-Dott, Sarah Christine Raßmuß, Marc-Michael Blum, Horst Thiermann, Harald John & Dirk Steinritz. (2023) Activation of the human TRPA1 channel by different alkylating sulfur and nitrogen mustards and structurally related chemotherapeutic drugs. Toxicology Letters 376, pages 51-59.
Crossref
Crossref
Ajaz A. Bhat, Salma N. Younes, Syed Shadab Raza, Lubna Zarif, Sabah Nisar, Ikhlak Ahmed, Rashid Mir, Sachin Kumar, Surender K. Sharawat, Sheema Hashem, Imadeldin Elfaki, Michal Kulinski, Shilpa Kuttikrishnan, Kirti S. Prabhu, Abdul Q. Khan, Santosh K. Yadav, Wael El-Rifai, Mohammad A. Zargar, Hatem Zayed, Mohammad Haris & Shahab Uddin. (2020) Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance. Molecular Cancer 19:1.
Crossref
Crossref
Thomas J. Kipps & Michael Y. Choi. (2019) Targeted Therapy in Chronic Lymphocytic Leukemia. The Cancer Journal 25:6, pages 378-385.
Crossref
Crossref
Jörg Mahlich, Shinichiro Okamoto & Akiko Tsubota. (2017) Cost of Illness of Japanese Patients with Chronic Lymphocytic Leukemia (CLL), and Budget Impact of the Market Introduction of Ibrutinib. PharmacoEconomics - Open 1:3, pages 195-202.
Crossref
Crossref
Thomas J. Kipps, Freda K. Stevenson, Catherine J. Wu, Carlo M. Croce, Graham Packham, William G. Wierda, Susan O'Brien, John Gribben & Kanti Rai. (2017) Chronic lymphocytic leukaemia. Nature Reviews Disease Primers 3:1.
Crossref
Crossref
C Arimany-Nardi, A Montraveta, E Lee-Vergés, X S Puente, H Koepsell, E Campo, D Colomer & M Pastor-Anglada. (2015) Human organic cation transporter 1 (hOCT1) as a mediator of bendamustine uptake and cytotoxicity in chronic lymphocytic leukemia (CLL) cells. The Pharmacogenomics Journal 15:4, pages 363-371.
Crossref
Crossref
Naoki Shimada, Koichiro Yuji, Nobuhiro Ohno, Tomohiko Koibuchi, Naoki Oyaizu, Kaoru Uchimaru & Arinobu Tojo. (2015)
Treatment of chronic lymphocytic leukemia with bendamustine in an
HIV
‐infected patient on antiretroviral therapy: a case report and review of the literature
. Clinical Case Reports 3:6, pages 453-460.
Crossref
Crossref
Zhimin Li, Thomas Caulfield, Yushi Qiu, John A. Copland & Han W. Tun. (2012) Pharmacokinetics of bendamustine in the central nervous system: chemoinformatic screening followed by validation in a murine model. MedChemComm 3:12, pages 1526.
Crossref
Crossref